State litigation guide · Pennsylvania

Tepezza Hearing Loss Lawsuit in Pennsylvania

Time limits apply in Pennsylvania. Find out if you still qualify.

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

People's Justice Research TeamUpdated July 25, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Statute of limitations — Pennsylvania

Pennsylvania Consolidated Statutes 42 Pa. C.S. § 5524 imposes a 2-year statute of limitations for personal injury claims including product liability. The discovery rule applies where the defect or its causal connection was not immediately discoverable — the clock starts when the plaintiff knew or should have known that Tepezza caused the hearing damage. Pennsylvania does not have a statute of repose for pharmaceutical product liability claims.

2 years from discovery of Tepezza-related hearing injury

Filing venue

Where to File in Pennsylvania

Federal Tepezza cases from Pennsylvania are transferred to the MDL in the Northern District of Illinois (MDL No. 3079). Pennsylvania state court claims may proceed in Philadelphia County Court of Common Pleas, which has historically been a favorable venue for pharmaceutical litigation. Pennsylvania applies a Frye standard for expert testimony in state courts. The state's strong tradition of pharmaceutical mass tort handling makes it a significant source of Tepezza claims.

Pennsylvania data

Exposure in Pennsylvania

Pennsylvania population — fifth-largest state with major medical centers in Philadelphia and Pittsburgh prescribing Tepezza for TED

13 million

Source: U.S. Census Bureau 2024

Year FDA approved Tepezza — original label did not warn of severe or permanent hearing loss; label updated July 2023

2020

Source: FDA drug approval records

Estimated individual Tepezza settlement range based on severity of hearing damage and supporting documentation

$75,000–$200,000+

Source: Mass tort litigation analyst projections

Keep reading